Very true, 3 S1s were filed with FINRA on 9/14/202
Post# of 36568
(Total Views: 388)
Posted On: 03/04/2021 12:10:33 PM
Very true, 3 S1s were filed with FINRA on 9/14/2020, without an update or EFFECTIVE. If I recall, it was stated they wanted the next 10K, which was filed on 10/29/2020. Then it was the next 10Q, which was filed on 12/15/2020. Then they needed the valuation to put a price tag to the shares, and that was received 2 months ago.
My point is that this is a brand new company that went thru all SEC questions and were cleared on 9/1/2020 to become officially public. Nasdaq is interested to know if NGIO has 1 year of cash on hand for operations, can pay the filing fee, and is cleared with the SEC, which was just done on 9/1/2020. This is a slam dunk. The only variable is can Dawson James find investors for NGIO IPO at $5+/share? So, since this is taking a bit longer, are they having trouble with investors? Or is NGIO asking for more than the $5/share?
Of course, all of this is my opinion and you should not make any investment decisions based on my opinion.
My point is that this is a brand new company that went thru all SEC questions and were cleared on 9/1/2020 to become officially public. Nasdaq is interested to know if NGIO has 1 year of cash on hand for operations, can pay the filing fee, and is cleared with the SEC, which was just done on 9/1/2020. This is a slam dunk. The only variable is can Dawson James find investors for NGIO IPO at $5+/share? So, since this is taking a bit longer, are they having trouble with investors? Or is NGIO asking for more than the $5/share?
Of course, all of this is my opinion and you should not make any investment decisions based on my opinion.
(6)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.